Integral Derivatives’s Colgate-Palmolive CL Stock Holding History

Integral Derivatives’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,325	Closed	-$743K	–	726
2017 Q4	$779K	Buy	10,325 +250	+2%	+$18.3K	0.02%	570
2017 Q3	$734K	Buy	10,075 +2,670	+36%	+$192K	0.01%	604
2017 Q2	$549K	Buy	+7,405	New	+$550K	0.01%	680
2015 Q2	–	Sell	-49,460	Closed	-$3.36M	–	1117
2015 Q1	$3.43M	Sell	49,460 -7,100	-13%	-$491K	0.07%	164
2014 Q4	$3.91M	Buy	56,560 +52,400	+1,260%	+$3.54M	0.07%	240
2014 Q3	$271K	Buy	+4,160	New	+$274K	﹤0.01%	1169
2014 Q2	–	Sell	-4,760	Closed	-$319K	–	1357
2014 Q1	$309K	Buy	4,760 +1,300	+38%	+$81.9K	0.01%	1039
2013 Q4	$226K	Buy	+3,460	New	+$221K	﹤0.01%	1319

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Integral Derivatives's CL Position: Q1 2018 in Review

Integral Derivatives sold out of Colgate-Palmolive (CL) in Q1 2018, closing a stake of 10,325 shares — an estimated $743K sold.

Integral Derivatives first reported a position in CL in Q4 2013 and held it in 8 quarters. The position peaked at $3.91M in Q4 2014. 1,439 funds tracked by Wall St. Rank hold CL as of Q1 2018.

Integral Derivatives reported no remaining Colgate-Palmolive position as of Q1 2018 after selling out during the quarter.
Integral Derivatives sold 10,325 Colgate-Palmolive shares in Q1 2018, an estimated $743K.
Integral Derivatives first reported a position in Colgate-Palmolive in Q4 2013 and held it in 8 quarters.
Integral Derivatives's Colgate-Palmolive position peaked at $3.91M in Q4 2014.
1,439 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2018.

Based on Integral Derivatives's 13F filing for Q1 2018, filed 19 Apr 2018.